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Abstract
Background: Screening for gestational diabetes mellitus (GDM) is routine during pregnancy in
many countries in the world. The screening programs are either based on general screening offered
to all pregnant women or risk factor based screening stipulated in local clinical guidelines. The aims
of this study were to investigate: 1) the compliance with local guidelines of screening for GDM and
2) the outcomes of pregnancy and birth in relation to risk factors of GDM and whether or not
exposed to oral glucose tolerance test (OGTT).
Methods: This study design was a population-based retrospective cross-sectional study of 822
women. A combination of questionnaire data and data collected from medical records was applied.
Compliance to the local guidelines of risk factor based screening for GDM was examined and a
comparison of outcomes of pregnancy and delivery in relation to risk factor groups for GDM was
performed.
Results: Of the 822 participants, 257 (31.3%) women fulfilled at least one criterion for being
exposed to screening for GDM according to the local clinical guidelines. However, only 79 (30.7%)
of these women were actually exposed to OGTT and of those correctly exposed for screening,
seven women were diagnosed with GDM. Women developing risk factors for GDM during
pregnancy had a substantially increased risk of giving birth to an infant with macrosomia.
Conclusion: Surprisingly low compliance with the local clinical guidelines for screening for GDM
during pregnancy was found. Furthermore, the prevalence of the risk factors of GDM in our study
was almost doubled compared to previous Swedish studies. Pregnant women developing risk
factors of GDM during pregnancy were found to be at substantially increased risk of giving birth to
an infant with macrosomia. There is a need of actions improving compliance to the local guidelines.
Background
Gestational diabetes mellitus (GDM) is defined as carbo-
hydrate intolerance that is initiated or detected during
pregnancy [1]. GDM is associated with other pregnancy
complications and is an indicator of future development
of diabetes mellitus type 2 [2]. In Sweden, the prevalence
of GDM is reported in 1.2 - 2.3% of the pregnant women
[3-6]. Since the 1990s, Sweden has officially adopted the
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European recommendation of selective screening for
GDM [7]. However, a Swedish audit of all local guidelines
for screening, diagnostics and treatment for GDM reveals
no national unified guidelines [8].
Risk factors for GDM may be categorized in maternal or
pregnancy-related factors. The risk factors include obesity,
multiparity, high maternal age, family history of diabetes
mellitus and a previous delivery with a macrosomic infant
[2]. Elevated levels of fasting plasma glucose [9], repeated
glucosuria and elevated levels of random plasma glucose
during pregnancy are pregnancy-related risk factors for
GDM [10] as well as accelerated foetal growth and poly-
hydramniosis [11].
Few studies have examined compliance with local guide-
lines of screening for GDM. In a Thai study, the compli-
ance to local guidelines for GDM screening was 78% of
the pregnant women [12]. Further, compliance of local
guidelines for GDM in Australia was 95.3% [13], while
the compliance rate in France was 80% [14]. Even though
the compliance rate is high in these studies, not all quali-
fied women underwent screening as recommended in the
local guidelines. Hence some women with GDM may go
undetected. Untreated GDM or impaired glucose toler-
ance (IGT) seem to increase the risk of adverse outcomes
such as macrosomia, and cesarean sections [15,16], as
well as an increased risk of preterm delivery [16].
The aims of this study were to investigate:
1. The compliance with local guidelines of screening
for GDM.
2. The outcomes of pregnancy and birth in relation to
risk factors of GDM and whether or not exposed to
oral glucose tolerance test (OGTT).
Method
The study design was a population-based, retrospective,
cross-sectional study combining data from a question-
naire with data of medical records. The Regional Ethical
Review Board, University of Umeå, Sweden, has approved
the study (Dnr 05-020M).
Procedure
The current study is an extension of a previous question-
naire study investigating low back and pelvic girdle pain
during pregnancy. The initial recruitment procedure has
been reported elsewhere in detail [17-19]. Data were gath-
ered between January 1, 2002 through April 30, 2002
from Umeå University Hospital (UUH) and Sunderby
Hospital (SH), both located in the northern part of Swe-
den. The initial data set for this study consisted of 891
women. Inclusion criteria for participation were delivery
after 23 gestational weeks and proficiency in the Swedish
language. All women participating in the initial study
were contacted through a letter sent by mail with informa-
tion of the extension of the study. It was explained in the
letter that they could withdraw from further participation
by returning a prepaid envelope with a note saying that
they declined further participation. After the informed
consent of the participants, comprehensive information
on the outcomes of pregnancy and childbirth was col-
lected from medical records and added to the previously
collected questionnaire data. The selection of the final
sample is presented in Figure 1. The participants in this
study consisted of 822 women, constituting 73.8% of the
total eligible population of 1114 women who had deliv-
ered within the two hospitals during the same period.
Questionnaire and medical data
The questionnaire covered different aspects of gynaeco-
logic and obstetric history of the participating women as
well as questions concerning life style before and during
pregnancy. Parts of these data have been presented in rela-
tion to low back and pelvic girdle pain [17-19]. From each
medical record, 75 items presenting maternal characteris-
tics and pregnancy outcomes were collected and added to
the questionnaire data. These items included the presence
of risk factors according to the local guidelines of GDM
screening, medical outcomes of pregnancy and birth, and
medical diagnosis using International Classification of
Diseases (ICD) version 10.
Local guidelines of screening for GDM
The local guidelines obtained for both catchment areas,
addresses the risk factors which indicates screening for
GDM. Compilation of local guidelines for each catchment
area is presented in Table 1. The majority of the criteria
were identical in the catchment areas. According to the
guidelines, the OGTT should be performed in early preg-
nancy in women with prior GDM and repeated at 28 ges-
tational weeks if the first OGTT were normal. Other risk
factors indicated that OGTT should be performed at 28
gestational weeks. Blood glucose levels were measured
independent of last meal of the pregnant woman at 4
times regularly during pregnancy in the SH catchment
area and at 5-6 times regularly during pregnancy in the
UUH area. When a high blood glucose value would be
detected, the OGTT should be performed immediately
independent of gestational age.
Definitions
Maternal measures
Hypertension was defined as blood pressure ≥140/90 mm
Hg. The hypertensive group consisted of the subgroups of
the ICD-10 codes, i.e. ICD O10.0 (pre-existing essential
hypertension complicating pregnancy, childbirth and theBMC Pregnancy and Childbirth 2009, 9:53 http://www.biomedcentral.com/1471-2393/9/53
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puerperium) and ICD O13 (gestational [pregnancy-
induced] hypertension without significant proteinuria).
Preeclampsia was defined as a blood pressure ≥140/90 mm
Hg with proteinuria of ≥1+ on a dipstick. The ICD-10
codes of O14 (gestational [pregnancy-induced] hyperten-
sion with significant proteinuria with all subcodes) and
O15 (eclampsia) were included as preeclampsia.
Preterm birth was defined as gestational age < 37 com-
pleted weeks. Gestational age was determined by ultra-
sound for almost all women.
Oral glucose tolerance test (OGTT) was used to screen for
GDM. All women received 75 g glucose after ≥8 hours of
fasting. Blood glucose level was measured after 2 hours.
The selection of the sample of participants Figure 1
The selection of the sample of participants.
Eligible women for the study 
n= 891 
 n= 871 
Non-participants: Women not willing 
to participate at the additional data 
collection procedure (n= 20) 
 Women leaving informed consent 
n= 849 
Non-participants: Women who had 
either emigrated, unknown addresses or 
protected identity (n= 22) 
 n= 827 
Excluded: Women with incomplete data 
or missing medical records (n= 22) 
Final sample of participants  
n= 822 
Excluded: Women diagnosed with 
diabetes mellitus type 1 or type 2 before 
pregnancy (n= 5) BMC Pregnancy and Childbirth 2009, 9:53 http://www.biomedcentral.com/1471-2393/9/53
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Gestational diabetes mellitus (GDM) was defined as the
ICD-10 code O24.4 diabetes mellitus arising in preg-
nancy. The risk factors indicating OGTT screening as well
as the cut-off threshold at OGTT identifying GDM diagno-
sis in the study regions are presented in Table 1.
Accelerated foetal growth was defined when at least two val-
ues of the symfys-fundus measures exceeded >2 standard
deviations (SD) recorded in the antenatal medical
records. Furthermore, the ICD-10 code O36.6 (maternal
care for excessive foetal growth) was also used for identi-
fying cases with accelerated foetal growth. Polyhydramnio-
sis  was defined using the ICD-10 code O40
polyhydramniosis.
Birth experience was the women's overall estimation of the
experience of birth. The women were asked to give a com-
prehensive assessment of their experience by marking a
Visual Analogue Scale (VAS) from 0 to 10, where anchors
where verbally defined as 0 = most negative and 10 = most
positive.
Neonatal measures
Macrosomia, was defined as ICD-10 code of P08.0 (excep-
tionally large baby or a recorded birth weight ≥4500 g).
Jaundice was defined as ICD-code P59.0 (neonatal jaun-
dice associated with preterm delivery) and P59.9 (neona-
tal jaundice, unspecified).
Hypoglycemia consisted of the ICD-10 codes P70.0 (syn-
drome of infant of mother with gestational diabetes) and
P70.4 (other neonatal hypoglycemia).
Non-participants
Some available data from the questionnaires allowed
comparisons between participants and non-participants.
The non-participants (n = 69) did not differ significantly
from participants (n = 822) concerning maternal age, par-
ity, educational level, gestational age at birth, mode of
delivery, or birth experience. A comprehensive description
of non-participants in the initial data collection has been
reported elsewhere [18].
Categorization of participants
To compare the characteristics and outcomes of women
with and without risk factors of GDM, the women were
categorized into groups based on presence of risk factors
as defined in the local guidelines (Figure 2). Firstly, all
women were dichotomized with respect the presence or
absence of GDM risk factors in their medical history. Sec-
ondly, within these two groups, all women were dichot-
omized with respect to developing GDM risk factors or
not during pregnancy. Based on these categorizations,
three groups of women with risk factors were identified.
1. Risk factor group1, R1: women with risk factors in
medical history and additional risk factors developing
during pregnancy.
2. Risk factor group 2, R2: women with risk factors in
their medical history.
3. Risk factor group 3, R3: women with risk factors
developing during pregnancy.
A fourth group of women with absence of any risk factors
in their medical history or during pregnancy (normal
group, NG) was also identified.
Statistical analysis
Statistical analyses were performed using the statistical
software package (SPSS, version 16.0). For analyses of cat-
egorical variables, the Chi square-test was performed. For
Table 1: Criteria indicating oral glucose tolerance test (OGTT) screening for gestational diabetes mellitus (GDM) and cut-off 
threshold value for GDM diagnosis according to the local guidelines 2002 within the two catchment areas.
Criteria indicating OGTT screening for GDM Cut-off threshold at 
OGTT indicating GDM diagnosis
Umeå University Hospital UUH) Sunderby Hospital (SH)
Risk factors in medical history
Family history of diabetes (parents and siblings) Yes Yes
Previous pregnancy with GDM Yes Yes
Previous child with birth weight ≥4500 g Yes Yes
Maternal body weight before pregnancy (kg) ≥90 ≥90
Body Mass Index, BMI (kg/m2)N o ≥33
Risk factors developed during pregnancy
Randomly controlled blood glucose level at any antenatal visit during 
pregnancy (mmol/l)
≥8.0 ≥7.1
Accelerated fetal growth Yes Yes
Polyhydramniosis Yes Yes
Cut-off threshold at 75 g OGTT indicating GDM diagnosis
2 hours blood glucose value (mmol/l) ≥9.0 ≥8.9BMC Pregnancy and Childbirth 2009, 9:53 http://www.biomedcentral.com/1471-2393/9/53
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small samples, the Fischer's exact test was applied. For
normally distributed continuous variables, the Student's
t-test and analysis of variance [ANOVA] were performed.
The Bonferroni procedure was used to control for multi-
ple testing. For variables with a skewed distribution, the
Kruskal-Wallis and Mann-Whitney tests were applied. The
level of significance was set at p = 0.05.
Univariate and stepwise multiple logistic regression anal-
yses were used to investigate the association between
exposures before and during pregnancy and outcomes of
pregnancy and birth. The analyses of risk factors were con-
ducted in two steps. All exposure variables were tested one
by one in separate, univariate analysis. In a second step,
all statistically significant variables in the univariate anal-
ysis were tested using multivariate logistic regression anal-
ysis. Significant variables were entered in a stepwise
manner. Results from the final model are presented as
odds ratios (ORs) with confidence interval (CI) 95%.
Three models were tested in the analysis. Model 1 con-
sisted of the group of women fulfilling the criteria of
OGTT being correctly exposed to the test and the normal
group of women with absence of GDM risk factors in their
medical history and during pregnancy. Model 2 was based
on the group of women fulfilling the criteria of OGTT and
not being exposed to the test, and the normal group of
women with the absence of GDM risk factors in their
medical history and during pregnancy. Finally, the third
model consisted of the women who fulfilled the criteria,
but were not exposed to the test and the women fulfilling
the criteria for OGTT and correctly exposed to the test.
Validity of the data
The internal and external validity of the questionnaire has
been discussed elsewhere. Twenty-five women completed
an identical questionnaire two to three weeks after the
first questionnaire and the consistency between the two
sets was high, with total agreement in majority of ques-
tions [17-19].
To test the internal validity of data from the medical
records, a control of 50 randomly selected medical jour-
nals was performed. Of the 3 750 items controlled, 5
items (0.1%) of incorrect data excerption were found and
corrected.
Categorization of participants depending on presence of risk factors for GDM Figure 2
Categorization of participants depending on presence of risk factors for GDM.
Participants 
n=822 
Risk factors in medical 
history 
n=170 
No risk factors in 
medical history 
n=652 
Developing risk factors 
during pregnancy 
Risk factor group 3, R3
n=87 
No risk factor during 
pregnancy 
Normal group, NG 
n=565 
Developing additional
risk factors during 
pregnancy 
Risk factor group 1, R1 
n=45 
No additional risk factor 
during pregnancy 
Risk factor group 2, R2 
n=125 BMC Pregnancy and Childbirth 2009, 9:53 http://www.biomedcentral.com/1471-2393/9/53
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Results
Risk factors and OGTT
At the first antenatal visit, at least one risk factor for GDM
in the medical history as stipulated in the local guidelines
was reported by 170 (20.7%) women. There were no sig-
nificant differences in prevalence of risk factors in medical
history between the two catchment areas. Among the
women with risk factors in their medical history diabetes
mellitus in family was the most frequent risk factor
(61%), followed by maternal body weight of 90 kg or
more and/or BMI ≥33 (38%), previous infant with birth
weight of 4500 g or more (14%) and previous pregnancy
with GDM (1%). As presented in Additional file 1,
women with risk factors in their medical history reported
more problems related to life style and had lower educa-
tional level. Most women were married or cohabiting with
their partner. The women with risk factors in their medical
history described their work as being less intellectually
stimulating (71.3% vs. 81.5%, p = 0.034). No differences
were found regarding other aspects of the work such as the
work being sedentary or psychologically demanding. Fur-
thermore, there were no significant differences concerning
the evaluation of the relationship with spouse/partner
and satisfaction with sex-life.
Risk factors developing during pregnancy were reported in
132 pregnancies (15.9%). Additional file 1 presents
maternal characteristics of pregnant women with risk fac-
tors for GDM in their medical history and/or developing
during pregnancy and pregnant women with no risk fac-
tors for GDM in their medical history. Of the 132 women,
45 women (33.6%) already had at least one risk factor for
GDM in their medical history. The most frequent risk fac-
tor developed during pregnancy was accelerated foetal
growth (59%), followed by random high blood glucose
value (42%) and polyhydramniosis (1%). The women
developing risk factors during pregnancy were signifi-
cantly heavier, 74.6 (± 16.9) kg vs. 65.5 (± 11.2) kg, p <
0.001 and correspondingly presenting a higher BMI 27.8
(± 5.9) vs. 24.3 (± 4.0), p < 0.001 compared to women not
developing risk factors of GDM during pregnancy. No
other significant differences were observed between the
women developing risk factors during pregnancy and
those who did not.
The 257 women included in the categories R1, R2 and R3
(ie. 31.3% of the total sample) fulfilled criteria for per-
forming OGTT as stipulated in the local clinical guide-
lines. However, only 84 women were actually exposed to
OGTT according to their medical records (Additional file
1). Five of the 84 women had no indication of OGTT pre-
sented in their medical records (although performed),
leaving 79 out of 257 (30.7%) women correctly exposed
to OGTT. Seven women (8.8%) of the women correctly
exposed of OGTT were diagnosed with GDM. Women in
R1 underwent an OGTT significantly more often com-
pared to the women in R2 or R3. Obesity was the most fre-
quent risk factor (in the medical history) in combination
with accelerated foetal growth during pregnancy in the R1.
Family history of diabetes mellitus was the most prevalent
risk factor for R2. Among the women in R3, accelerated
foetal growth was the most prevalent risk factor. As pre-
sented in Additional file 1, the women included in the R1
were significantly more obese than the women included
in the other risk factor groups, even when a body weight
≥90 kg was one of the risk factors.
Outcomes of pregnancy and birth in relation to risk factor 
groups
The outcomes of pregnancy and birth in relation to risk
factor groups are presented in Table 2. The mean birth
weight was significantly higher in R1 and R3 as well as the
mean placenta weight in relation to NG. The correlation
coefficient between birth weight and placental weight
(subjects with twin pregnancies and/or preterm birth were
excluded from the analysis) was r2 = 0.41, p < 0.001. Sim-
ilar results for the four subgroups were r2 (R1) = 0. 51, r2
(R2) = 0. 42, r2 (R3) = 0.39 and r2(NG) = 0.34. There were
no significant differences between the subgroups concern-
ing mode of delivery, preterm delivery, induction of
labour, haemorrhage, Apgar score, pH of the umbilical
cord blood, and proportion of children referred to neona-
tal intensive care unit. Nor were there any significant dif-
ferences concerning jaundice or hypoglycaemia of the
infant observed. Women developing risk factors during
pregnancy (R1 and R3) had significantly more often been
exposed to induced labour (19% vs. 12%, p = 0.037) com-
pared to women with no risk factors during pregnancy (R2
and NG). The birth experience did not show significant
differences between the subgroups, although women with
risk factors in their medical history (R1 and R2) expressed
significantly more negative birth experience scores; 7.6 (±
2.4) vs. 8.0 (± 2.0), p = 0.026 compared to women with
no risk factors in their medical history (R3 and NG).
Risk of macrosomic infant
In univariate logistic regression analysis, delivery of mac-
rosomic infant was significantly associated with the deter-
minants: multiparity (≥3 children), education lower than
university level, previous infant with macrosomia, mater-
nal bodyweight ≥90 kg, accelerated foetal growth, being
correctly exposed to OGTT and weight gain of 16 kg or
more during pregnancy. In the stepwise multiple logistic
regression model, the determinants previous infant with
macrosomia (OR 17.77, 95% CI 1.38-229.15) and mater-
nal body weight ≥90 kg at entrance of pregnancy (OR
17.80, 95% CI 1.06-299.40) remained significant.
R1 demonstrated an increased risk of a macrosomic infant
(OR 5.65, 95% CI 2.64-12.11) as did R3 (OR 3.48, 95%BMC Pregnancy and Childbirth 2009, 9:53 http://www.biomedcentral.com/1471-2393/9/53
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CI 1.27-9.57) in relation to NG. Adjusting for multiparity
(≥3 children), education less than university level, mater-
nal body weigh ≥90 kg at entrance of pregnancy and
weight gain of ≥16 kg, R1 had a substantially increased
risk (OR 9.33, 95% CI 2.65-32.87) of giving birth to a
macrosomic infant as did women in R3 (OR 12.96, 95%
CI 1.33-126.63) compared to NG.
Outcomes of pregnancy and birth for women correctly 
exposed to OGTT and women fulfilling criteria of OGTT 
but not exposed to OGTT
R2 and R3 had an increased risk of non-exposure to OGTT
in relation to R1 (R2: OR 7.01, 95% CI 3.30-14.89 and R3:
OR 8.49, 95% CI 3.75-19.21). As presented in Additional
files 2 and 3, women fulfilling criteria of OGTT and cor-
rectly exposed to OGTT and the women fulfilling criteria
but not exposed, gave birth to infants with macrosomia
significantly more frequent compared to NG. In the step-
wise multiple regression, the risk of an infant with macro-
somia was more than 4-folded for the women correctly
exposed to OGTT and more than 5-folded for the women
not exposed to OGTT. As presented in Additional file 4, in
the univariate analysis, women fulfilling criteria, however
not exposed to OGTT presented decreased risk of obesity,
diastolic blood pressure of ≥140 mm Hg, proteinuria and
macrosomia. Further, a more negative birth experience
was found among these women compared to women cor-
rectly exposed to OGTT. However, in the stepwise multi-
ple regression analysis, only the outcome of a decreased
risk of developing proteinuria during pregnancy remained
significant. Adjusting for all risk factors of GDM (as
defined in the local guidelines), women with the lowest
education level had an increased risk (OR 6.19, 95% CI
1.58-24.27) of not being correctly exposed to OGTT when
fulfilling the criteria for performing the test in relation to
women with university education.
Table 2: Statistical comparisons of outcomes of pregnancy and birth for women in study groups
Risk factors for GDM in medical history
(n = 170)
No risk factors for GDM in medical history
(n = 652)
P value
Risk factor group 1, 
R1†
(n = 45)
Risk factor group 2, 
R2†
(n = 125)
Risk factor group 3, 
R3†
(n = 87)
Normal group, NG†
(n = 565)
Maternal weight gain in 
kg during pregnancy, 
mean (± SD)
11.01 (± 7,3) 12.4 (± 5,5) 13.82 (± 5,7) 12.8 (± 4,8) 0.028
Highest systolic blood 
pressure (mm Hg), 
median (25 - 75 quartiles)
1402 (125-147) 1302 (120-140) 1302 (120-135) 125 2 (120-133) < 0.001
Highest diastolic blood 
pressure (mm Hg), 
median (25 - 75 quartiles)
87 3 (80-95) 80 (75-85) 80 (75-85) 80 (73-84) < 0.001
Highest random blood 
glucose value (mmol/l), 
median (25 - 75 quartiles)
6.7 4 (5,7-8,0) 5.7 (5,3-6,2) 6.7 4 (5,6-7,7) 5.6 (5,1-6,2) < 0.001
Proteinurea during 
pregnancy
18 (40%) 25 (20%) 18 (21%) 112 (20%) 0.017
Preeclampsia, ICD-10 
codes O14+O15
5 (11%) 6 (5%) 4 (5%) 22 (4%) 0.172
Gestational weeks at 
birth, mean (± SD)
39.1 (± 1.89) 39.0 (± 2.22) 39.1 (± 2.24) 39.0 (± 2.16) 0.964
Birth weight of child (g), 
mean (± SD)
39585 (± 673) 35705 (± 709) 37735 (± 703) 3469 (± 600) < 0.001
Weight of placenta (g), 
median (25-75 quartiles)
6926 (609-800) 6326 (520-705) 6706 (600-790) 5856 (509-660) < 0.001
Birth experience*, mean 
(± SD)
7.36 (± 2,3) 7.69 (± 2,5) 7.74 (± 2,4) 8.04 (± 1.9) 0.064
† R1: Women with risk factors for GDM in medical history and developing additional risk factors during pregnancy, R2: Women with risk factors for 
GDM in medical history and not developing additional risk factors during pregnancy, R3: Women with no risk factors for GDM in medical history 
and developing additional risk factors during pregnancy and NG: Women with no risk factors for GDM in medical history nor during pregnancy
* The women's overall experience of birth was expressed on a scale where the anchors where verbally defined as 1 = very negative and 10 = very 
positive.
1/R1 vs. R3 p-value = 0.022; 2/R1 vs. NG p < 0.001, R1 vs. R2 p = 0.004, R1 vs. R3 p = 0.003, R2 vs. NG p = 0.032, R2 vs. R3 p = ns, R3 vs. NG p = 
0.022; 3/R1 vs. R2, R3 and NG p < 0.001; 4/R1 and R3 vs. R 2 and NG p < 0.001; 5/R1 and R3 vs. NG p < 0.001, R1 vs. R2 p = 0.003; 6/R1 vs. NG p 
< 0.001, R1 vs. R2 p = 0.004, R1 vs. R3 ns, R2 vs. NG p = 0.004, R2 vs. R3 p = 0.04, R3 vs. NG p < 0.001BMC Pregnancy and Childbirth 2009, 9:53 http://www.biomedcentral.com/1471-2393/9/53
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Discussion
The findings in this study within a Swedish context indi-
cate surprisingly low compliance with the local guidelines
for screening pregnant women for GDM. Close to one
third of all pregnant women presented at least one risk
factor of GDM in their medical history or a risk factor
developing during pregnancy. Furthermore, women
developing risk factors for GDM during pregnancy were at
increased risk of giving birth to an infant with macro-
somia.
In the 1990s in Australia, half of the pregnant women
were not screened for GDM during pregnancy despite the
recommendation of OGTT screening for all pregnant
women [20]. In the last couple of years, the reported com-
pliance ranged from 78% - 92.1% [12-14]. These studies
demonstrate considerably higher prevalence of performed
screening for GDM compared to our study. The current
study did not investigate the possible causes to the low
compliance to the local guidelines of screening for GDM.
The women were commonly referred to the clinical labo-
ratory at the local health care centre or the nearby hospital
for the performance of OGTT. This situation might have
negatively influenced the patient adherence in relation to
OGTT performed within the midwifery service. Another
possible explanation could be that some pregnant women
might have refused to undergo OGTT. Further, risk factors
in the medical history might not have been correctly
observed by the midwives. The medical history was rou-
tinely requested at the first antenatal visit, but by the time
of arrangement for the OGTT, this initial information of
risk factors might have been overlooked.
Obesity is one of the risk factors indicating screening for
GDM, and obesity might be a sensitive topic to approach
for midwives. It has been reported that nurses are aware of
the obesity stigma, which implies communication tactics,
such as softening the terms and avoiding the term 'obesity'
due to its negative connotations. This strategy has been
applied to deal with the sensitivity and maintain good
relationship [21]. Moreover, by increasing the knowledge
and competence of midwives in addressing sensitive
issues, improved communication skills might be
achieved, which may be beneficial for the pregnant
women.
The prevalence of the risk factors for GDM in the medical
history in a Swedish population has previously been esti-
mated to reach 15.8%. This estimation is based on the risk
factors family history of diabetes mellitus, maternal body
weight ≥90 kg, prior delivery of an infant of ≥4500 g (ie.
macrosomia) or prior GDM [3]. In our study, the preva-
lence of risk factors among the pregnant population was
higher; 20.7% of the pregnant women had at least one of
the risk factors for GDM in their medical history. Adding
the risk factors developing during pregnancy, almost one
third (31.3%) of all pregnant women had risk factors indi-
cating risk for developing GDM. Despite the recommen-
dations of OGTT stipulated in the local guidelines, merely
one in three pregnant women with risk factors underwent
an OGTT. In the present study, the local guidelines indi-
cated a body weight of 90 kg as a cut-off value for screen-
ing because of obesity. This cut-off level may be
questioned since a short woman with a body weight
below the cut-off level may be obese, hence at risk for
GDM. This was the case in our material as 6% of the par-
ticipants with absence of risk factors in the medical history
had a BMI corresponding to obesity, but did not fulfill the
criteria of the risk factor body weight in the local guide-
lines. The risk of development of GDM during pregnancy
is doubled at BMI 25-29.9 and six-folded at BMI ≥30 com-
pared to pregnant women with normal BMI [22]. A
national audit of all local guidelines for GDM screening in
Sweden shows that a cut-off value of 90 kg for body
weight as an indicator for obesity was applied in 28% of
the local guidelines [8].
There is an ongoing international debate on the value of
GDM screening programs. There are some suggestions
that screening for GDM in all pregnant women may
improve maternal and foetal outcomes [23,24], and some
evidence that treatment of GDM after 24 gestational
weeks improves maternal and foetal outcomes [24]. Oth-
ers propose temporary suspension of the screening and
treatment for GDM or elevating the cut-off threshold indi-
cating a GDM diagnosis until a clear benefit of an inter-
vention has been presented [25]. In Sweden, there is no
national consensus addressing the screening for GDM,
thus there are regions with general screening as well as
regions with selective screening based on risk factors [8].
In a recent publication from the Hyperglycemia and
Adverse Pregnancy Outcome (HAPO) study, the authors
conclude that there is no specific threshold at which risks
for adverse outcomes increase. Increased birth weights are
observed even when maternal blood glucose level is
below the values indicating GDM [26]. The same relation
may be the case in our study as R1 and R3 demonstrated
significantly higher random glucose levels and further, an
increased risk of delivery of a macrosomic infant.
Strong associations with subsequent development of dia-
betes mellitus type 2 (DM2) after GDM have been
reported. A systematic review reports that the cumulative
incidence after the index pregnancy with GDM ranges
between 2.6% to over 70% depending on the follow-up
period [27]. Recently, the increased risk of DM2 after a
previous GDM was estimated to more than 7-folded in
relation to women with normal blood glucose levels dur-
ing pregnancy [28]. Scandinavian studies show that 35 -
41% of women with previous GDM develop DM2 withinBMC Pregnancy and Childbirth 2009, 9:53 http://www.biomedcentral.com/1471-2393/9/53
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10 - 15 years [29,30]. Regarding these aspects, the low
compliance to the local guidelines in our study must be
considered disadvantageous. Close to one third of the
pregnant women in the current study was characterized by
having at least one risk factor for developing GDM during
pregnancy, a situation that highlights an increasing prob-
lem within public health of women. Evidently, not all
women with risk factors for GDM will develop GDM dur-
ing pregnancy; however the midwives identify women
with a number of health problems who might benefit
from health interventions that could improve women's
future health.
Methodological considerations
In Sweden, almost all deliveries take place in hospitals.
Since less than 0.5/1000 are planned home births [31],
the population-based design with data collection before
discharge from hospital after childbirth accurately reflect
the population. The validity of the data from the question-
naires has been extensively discussed elsewhere [17-19].
The current study combined data from medical records
with self-reported results from a questionnaire. Further-
more, the data were collected within two separate regions
in the northern part of Sweden.
A retrospective data collection procedure may induce
recall-bias. However, the accuracy of perinatal informa-
tion has been reported as very good even four to six years
after childbirth [32]. The data from the women were col-
lected within the first days after delivery and birth in our
study, which most probably will account for accurate
memories and statements by the participants. However,
the accuracy of midwives' and physicians' documentation
may be questioned. The documentation in medical
records by midwives and physicians show that midwives
have higher accuracy of recorded medical conditions,
pregnancy complications, intrapartum and postpartum
events than physicians in a study in the USA [33]. A vali-
dation of the excerpted data in the current study was per-
formed showing that only a few items were incorrect.
In order to improve the compliance to the local guide-
lines, the OGTTs could preferably be performed within
the midwifery service. Furthermore, there is a need of
national consensus of the design of a screening program
for GDM. Further studies should address the issue of com-
pliance with local guidelines to verify whether these find-
ings are general. Future studies may address midwives'
attitudes toward obesity and women with low educational
levels. Furthermore, investigation of whether interven-
tions regarding diet and blood glucose levels may influ-
ence the prevalence of macrosomia among women
developing risk factors during pregnancy should be con-
ducted.
Conclusion
In conclusion, a surprisingly low compliance with the
local guidelines of screening for GDM was found. Further-
more, the prevalence of the risk factors for GDM in our
study was almost doubled compared to previous Swedish
studies. Pregnant women developing risk factors of GDM
during pregnancy were found to be at increased risk of giv-
ing birth to an infant with macrosomia.
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